Showing 1711-1720 of 10609 results for "".
Exploring Patient-Reported Outcomes Measures in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/exploring-patient-reported-outcomes-measures-in-atopic-dermatitis/23886/Patient-reported outcomes may solve some of the challenges with measuring the physical and psychosocial manifestations.Contact Dermatitis and Hair Care
https://practicaldermatology.com/topics/feature/contact-dermatitis-and-hair-care/29190/Hair care products can have a significant effect on the health of the skin, and contribute to other skin issues, including acne, dry scalp, and even hair shedding.Go Big or Go Home? Taking MIPS to The Max
https://practicaldermatology.com/topics/practice-management/go-big-or-go-home-taking-mips-to-the-max/20696/Part three in a three-part series on the MIPS “pick-your-pace” transition.Counting Our Blessings: What to Celebrate In Dermatology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/counting-our-blessings-what-to-celebrate-in-dermatology/20289/It can be tempting to lose sight of what we love about dermatology. Don't fall into the trap.Easing Further Down The Road: Getting Comfortable with MIPS
https://practicaldermatology.com/topics/practice-management/easing-further-down-the-road-getting-comfortable-with-mips/20715/Part two of a three-part series on the MIPS “pick-your-pace” transition.Cloning & Coding: Another EHR Controversy Rises
https://practicaldermatology.com/topics/practice-management/cloning--coding-another-ehr-controversy-rises/21549/“Upcoding” is the latest unanticipated chapter in the long-running regulatory saga of EHRs.Take 5: Innovations in Aesthetic Treatments
https://practicaldermatology.com/columns/take-5/take-5-innovations-in-aesthetic-treatments/21746/Five new or emerging products may expand skin rejuvenation options.DermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.DermwireTV — Revance’s Neurotoxin Promising, Celebs Fight Melanoma with L’Oreal
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-revance-rsquo-s-neurotoxin-promising-celebs-fight-melanoma-with-l-rsquo-oreal/19138/In this weeks DermwireTV, patient safety is explored, L'Oreal supports melanoma research and Revance reports positive data for novel neurotoxin.Nickel Barrier Methods
https://practicaldermatology.com/topics/atopic-dermatitis/nickel-barrier-methods/20465/Do they affect instrument sound?